THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death "THALES"

Recruiting

Phase 3 Results N/A

Summary of Purpose

Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 March 2018.

22 Jan 2018 20 Nov 2017 16 Dec 2019 16 Dec 2019 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts